New study aims to find safest treatment path for rare cancer patients
NCT ID NCT07471425
First seen Mar 19, 2026 · Last updated May 09, 2026 · Updated 4 times
Summary
This study will follow 1,100 people with advanced neuroendocrine tumors (NETs) to see which treatments or treatment sequences cause the fewest long-term, limiting side effects. The goal is to create a tool that helps doctors choose the best therapy for each patient. Participants must have a new or untreated NET that cannot be removed by surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE (NE) TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
APHM Marseille La Timone
Marseille, 13005, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
APHP Beaujon
Clichy, 92110, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
APHP Cochin
Paris, 75014, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHRU Tours
Tours, 37044, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Caen
Caen, 14000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Clermont Ferrand
Clermont-Ferrand, 63000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Dijon
Dijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Lille
Lille, 59000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Poitiers
Poitiers, 86196, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Reims
Reims, 51092, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Strasbourg
Strasbourg, 67200, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Toulouse
Toulouse, 31300, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Eugene Maquis
Rennes, 35000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Edouard Herriot
Lyon, 69003, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.